Filing Details
- Accession Number:
- 0001110803-14-000302
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-03 20:10:45
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-03
- Accepted Time:
- 2014-09-03 20:10:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566173 | Michel Bouchard | 5200 Illumina Way San Diego CA 92122 | Vp, Finance & Chief Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-02 | 631 | $69.34 | 24,876 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 631 | $180.07 | 24,245 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-02 | 55 | $180.03 | 24,190 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-09-02 | 631 | $0.00 | 631 | $69.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,157 | 2011-02-28 | 2021-01-31 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 631 shares sold ranging from $180.00 to $180.275 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Balance includes 55 shares acquired on Aug. 1, 2014 through Employee Stock Purchase Plan.
Billionaire Hedge Funds
